Molecular Diagnostics
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Urine Analyzer
respons® UDS100
In Other News
Study Confirms Barrett’s Esophagus as Precursor to Esophageal Cancer
AI Tool Predicts Bevacizumab Non-Response in Metastatic Colorectal Cancer
Automated Sample Preparation System Standardizes Pre-Analytical Workflow for MRD and Liquid Biopsy
Urine-Based Assay Predicts Severe Dengue Risk Early
CE-Marked Blood Test Enables Monitoring of Neuroinflammation in Multiple Sclerosis
Ultrasensitive Assay Tracks Resistance Mutations MRD Monitoring
Extracellular Vesicle RNA Biomarkers Enable Noninvasive IBD Diagnosis and Monitoring
FDA Clears At-Home HPV Test with Extended Genotyping for Cervical Screening
New Gene Signature Reveals Underdiagnosed Lung Cancer Subtype
Genome Sequencing Identifies Noncoding Variants Causing Neonatal Diabetes
Genetic Markers Predict GLP-1 Weight-Loss Response and Side Effects
Noninvasive Urine Test Predicts Recurrence After BCG in Bladder Cancer
Mesothelioma in Younger Adults Linked to Genetic Risk Factors
Immune Signatures in Blood Help Inform Cancer Risk in Lynch Syndrome
Genetic Marker Predicts Early Heart Failure in Pulmonary Arterial Hypertension
Genomic Subtyping Assays Identify High-Risk Early-Stage Breast Cancers
Simple Blood Test Enables Multi-Disease Detection from Single Sample
Rapid Point-of-Care RT-PCR Test Differentiates Influenza A/B and SARS-CoV-2 in Minutes
ctDNA MRD Test Identifies Breast Cancer Patients Who May Avoid Surgery
WGS MCED Assay Demonstrates Rising Sensitivity and High Specificity
Blood-Based ctDNA Test Enhances Risk Assessment in HPV-Related Throat Cancer
RNA Profiling Uncovers Therapeutic Targets in Solid Tumors
AI-Based Blood Test Diagnose Multiple Brain Disorders from Blood Sample
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
